Current Challenges in the Development of Platelet‐Rich Plasma‐Based Therapies

Abstract

Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet‐rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP‐obtaining methods that attempt to modify the molecular composition of the plasma.